MR [Mindray Medical International] SC 13G: 13G CUSIP No. 602675100 Page 14 of 15

[13G CUSIP No. 602675100 Page 14 of 15 Joint Filing Agreement February 13, 2014 This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument. Commonwealth Bank of Australia Margaret Taylor Company Secretary Colonial Holding Company Limited Michael Venter Director Commonwealth Insurance Holdings Limited Michael Venter Director Colonial First State Group] [13G CUSIP No. 602675100 Page 15 of 15 Item 7 Information The securities being reported on by the reporting persons herein as parent holding companies are owned, or may be deemed to be beneficially owned as follows: Company Type of Company First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International Ltd. IA (US registered) First State] [13G CUSIP No. 602675100 Page 2 of 15 1. Name of reporting person S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Commonwealth Bank of Australia 2. Check the appropriate box if a member of a group ¨ x (a) 3. SEC use only 4. Citizenship or place of organization Australian Capital Territory, Commonwealth of Australia Number of shares beneficially owned]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[SCHEDULE 13G 01 (Amendment No. Mindray Medical International LTD (Name of Issuer) ADR 602675100 December 31, 2013 x o o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]

MR [Mindray Medical International] SC 13G/A: SCHEDULE 13G 01 (Amendment No. Mindray Medical International

[SCHEDULE 13G 01 (Amendment No. Mindray Medical International LTD (Name of Issuer) ADR 602675100 December 31, 2013 x o o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]

MR [Mindray Medical International] SC 13G/A: Joint Filing Agreement February 10, 2014 Li Xiting

[Joint Filing Agreement February 10, 2014 Li Xiting Quiet Well Limited Li Xiting Director EX-99.(A) 2 d665989dex99a.htm EX-99.(A)] [1 Names of reporting persons/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Li Xiting 2 Check the appropriate box if a member of a group ¨ x (a) 3 SEC use only 4 Citizenship or place of organization People’s Republic of China Number of shares beneficially owned by each reporting person with 5 Sole voting power (1)(2) 16,593,569 6 Shared]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[Joint Filing Agreement February 10, 2014 Li Xiting Quiet Well Limited Li Xiting Director EX-99.(A) 2 d665989dex99a.htm EX-99.(A)] [1 Names of reporting persons/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Li Xiting 2 Check the appropriate box if a member of a group ¨ x (a) 3 SEC use only 4 Citizenship or place of organization People’s Republic of China Number of shares beneficially owned by each reporting person with 5 Sole voting power (1)(2) 16,593,569 6 Shared]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[CUSIP No.: 602675100 1. Names of Reporting Persons: Manning & Napier Advisors, LLC I.R.S. Identification Nos. of above persons (entities only): 45-3240790 2. Check the Appropriate Box if a Member of a Group (See Instructions): ¨ ¨ (a) 3. SEC Use Only: 4. Citizenship or Place of Organization: New York Number of Shares Beneficially Owned by Each Reporting Person With:]

MR [Mindray Medical International] SC 13G/A: CUSIP No.: 602675100 1. Names of Reporting Persons:

[CUSIP No.: 602675100 1. Names of Reporting Persons: Manning & Napier Advisors, LLC I.R.S. Identification Nos. of above persons (entities only): 45-3240790 2. Check the Appropriate Box if a Member of a Group (See Instructions): ¨ ¨ (a) 3. SEC Use Only: 4. Citizenship or Place of Organization: New York Number of Shares Beneficially Owned by Each Reporting Person With:]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 6771309 Shares Bene ______________________________________________________]

MR [Mindray Medical International] SC 13G/A: 1. Names of Reporting Persons. I.R.S. Identification Nos.

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 6771309 Shares Bene ______________________________________________________]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance SHENZHEN, China, January 13, 2014 -- Mindray Medical International Limited (“Mindray,” NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2013. The company also provided net revenue guidance for 2014. For the year] []

Skip to toolbar